Published in Vaccine on April 02, 2011
Induction of virus-specific cytotoxic T lymphocytes as a basis for the development of broadly protective influenza vaccines. J Biomed Biotechnol (2011) 1.13
H9N2 avian influenza virus in Korea: evolution and vaccination. Clin Exp Vaccine Res (2013) 1.03
Astragalus polysaccharide enhances immunity and inhibits H9N2 avian influenza virus in vitro and in vivo. J Anim Sci Biotechnol (2013) 0.93
Immune responses in mice vaccinated with virus-like particles composed of the GP5 and M proteins of porcine reproductive and respiratory syndrome virus. Arch Virol (2013) 0.90
Protective efficacy of crude virus-like particle vaccine against HPAI H5N1 in chickens and its application on DIVA strategy. Influenza Other Respir Viruses (2012) 0.87
A review of vaccine development and research for industry animals in Korea. Clin Exp Vaccine Res (2012) 0.83
Virus-like particle vaccine protects against H3N2 canine influenza virus in dog. Vaccine (2013) 0.82
Characterization and Comparison of the Structural Features, Immune-Modulatory and Anti-Avian Influenza Virus Activities Conferred by Three Algal Sulfated Polysaccharides. Mar Drugs (2015) 0.80
Bursopentine as a novel immunoadjuvant enhances both humoral and cell-mediated immune responses to inactivated H9N2 Avian Influenza virus in chickens. Clin Vaccine Immunol (2011) 0.80
Characterization of Humoral Responses Induced by an H7N9 Influenza Virus-Like Particle Vaccine in BALB/C Mice. Viruses (2015) 0.79
Influenza Virus-like Particle Containing Two Different Subtypes of Hemagglutinin Confers Protection in Mice Against Lethal Challenge With A/PR8 (H1N1) and A/HK (H3N2) Viruses. Iran Red Crescent Med J (2013) 0.78
Production and evaluation of virus-like particles displaying immunogenic epitopes of porcine reproductive and respiratory syndrome virus (PRRSV). Int J Mol Sci (2015) 0.77
Virus-like particle vaccine confers protection against a lethal newcastle disease virus challenge in chickens and allows a strategy of differentiating infected from vaccinated animals. Clin Vaccine Immunol (2014) 0.77
Progress and hurdles in the development of influenza virus-like particle vaccines for veterinary use. Clin Exp Vaccine Res (2014) 0.77
Dual function of the hemagglutinin H5 fused to chicken CD154 in a potential strategy of DIVA against avian influenza disease: preliminary study. Open Vet J (2015) 0.75
Progress in developing virus-like particle influenza vaccines. Expert Rev Vaccines (2016) 0.75
Current situation of H9N2 subtype avian influenza in China. Vet Res (2017) 0.75
Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus. J Virol (2007) 2.71
Induction of heterosubtypic immunity to influenza virus by intranasal immunization. J Virol (2007) 2.06
Induction of long-term protective immune responses by influenza H5N1 virus-like particles. PLoS One (2009) 1.95
Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity. J Control Release (2009) 1.62
Influenza vaccines based on virus-like particles. Virus Res (2009) 1.48
Stabilization of influenza vaccine enhances protection by microneedle delivery in the mouse skin. PLoS One (2009) 1.42
Influenza virus-like particles containing M2 induce broadly cross protective immunity. PLoS One (2011) 1.40
Protective immunity against H5N1 influenza virus by a single dose vaccination with virus-like particles. Virology (2010) 1.39
Enhanced memory responses to seasonal H1N1 influenza vaccination of the skin with the use of vaccine-coated microneedles. J Infect Dis (2010) 1.36
Incorporation of membrane-anchored flagellin into influenza virus-like particles enhances the breadth of immune responses. J Virol (2008) 1.34
Transcutaneous immunization with inactivated influenza virus induces protective immune responses. Vaccine (2006) 1.33
Ginseng and Salviae herbs play a role as immune activators and modulate immune responses during influenza virus infection. Vaccine (2006) 1.32
Virus-like particles containing multiple M2 extracellular domains confer improved cross-protection against various subtypes of influenza virus. Mol Ther (2012) 1.31
Virus-like particle vaccine protects against 2009 H1N1 pandemic influenza virus in mice. PLoS One (2010) 1.28
Incorporation of high levels of chimeric human immunodeficiency virus envelope glycoproteins into virus-like particles. J Virol (2007) 1.25
A bivalent influenza VLP vaccine confers complete inhibition of virus replication in lungs. Vaccine (2008) 1.24
Viruslike particle vaccine induces protection against respiratory syncytial virus infection in mice. J Infect Dis (2011) 1.24
Gene expression profiling of cancer stem cell in human lung adenocarcinoma A549 cells. Mol Cancer (2007) 1.22
Vaccination inducing broad and improved cross protection against multiple subtypes of influenza A virus. Proc Natl Acad Sci U S A (2010) 1.22
Intradermal vaccination with influenza virus-like particles by using microneedles induces protection superior to that with intramuscular immunization. J Virol (2010) 1.22
The immunomodulator ginsan induces resistance to experimental sepsis by inhibiting Toll-like receptor-mediated inflammatory signals. Eur J Immunol (2006) 1.20
Kinetics of immune responses to influenza virus-like particles and dose-dependence of protection with a single vaccination. J Virol (2009) 1.20
DNA barcoding techniques for avian influenza virus surveillance in migratory bird habitats. J Wildl Dis (2010) 1.20
TCL1 participates in early embryonic development and is overexpressed in human seminomas. Proc Natl Acad Sci U S A (2002) 1.19
Protection of Staphylococcus aureus-infected septic mice by suppression of early acute inflammation and enhanced antimicrobial activity by ginsan. FEMS Immunol Med Microbiol (2006) 1.17
Improved influenza vaccination in the skin using vaccine coated microneedles. Vaccine (2009) 1.16
Human immunodeficiency virus-like particles activate multiple types of immune cells. Virology (2007) 1.16
Nationwide groundwater surveillance of noroviruses in South Korea, 2008. Appl Environ Microbiol (2010) 1.09
Enhancement of mucosal immune responses by chimeric influenza HA/SHIV virus-like particles. Virology (2003) 1.07
Evidence of intercontinental transfer of North American lineage avian influenza virus into Korea. Infect Genet Evol (2010) 1.06
Intranasal immunization with influenza VLPs incorporating membrane-anchored flagellin induces strong heterosubtypic protection. PLoS One (2010) 1.06
Dose sparing enabled by skin immunization with influenza virus-like particle vaccine using microneedles. J Control Release (2010) 1.05
Molecular epidemiology of rabies virus isolates from South Korea. Virus Res (2005) 1.05
Stability of influenza vaccine coated onto microneedles. Biomaterials (2012) 1.04
Stability kinetics of influenza vaccine coated onto microneedles during drying and storage. Pharm Res (2010) 1.03
Inhaled hydrogen gas therapy for prevention of testicular ischemia/reperfusion injury in rats. J Pediatr Surg (2012) 1.03
Protective effect of ginseng polysaccharides on influenza viral infection. PLoS One (2012) 1.03
Improved protection against avian influenza H5N1 virus by a single vaccination with virus-like particles in skin using microneedles. Antiviral Res (2010) 1.03
H9N2 avian influenza virus in Korea: evolution and vaccination. Clin Exp Vaccine Res (2013) 1.03
Continuing evolution and interspecies transmission of influenza viruses in live bird markets in Korea. Avian Dis (2010) 1.02
Microneedle delivery of H5N1 influenza virus-like particles to the skin induces long-lasting B- and T-cell responses in mice. Clin Vaccine Immunol (2010) 1.01
MyD88 plays an essential role in inducing B cells capable of differentiating into antibody-secreting cells after vaccination. J Virol (2011) 1.00
Antibiotic resistance profiles of Staphylococcus pseudintermedius isolates from canine patients in Korea. J Microbiol Biotechnol (2010) 1.00
Enhanced influenza virus-like particle vaccines containing the extracellular domain of matrix protein 2 and a Toll-like receptor ligand. Clin Vaccine Immunol (2012) 0.99
Intranasal administration of live Lactobacillus species facilitates protection against influenza virus infection in mice. Antiviral Res (2011) 0.98
Formulation of microneedles coated with influenza virus-like particle vaccine. AAPS PharmSciTech (2010) 0.98
Analysis of complete genome sequences of swine hepatitis E virus and possible risk factors for transmission of HEV to humans in Korea. J Med Virol (2010) 0.97
Multiple heterologous M2 extracellular domains presented on virus-like particles confer broader and stronger M2 immunity than live influenza A virus infection. Antiviral Res (2013) 0.97
Influenza M1 VLPs containing neuraminidase induce heterosubtypic cross-protection. Virology (2012) 0.97
Protective effect of Korean red ginseng extract on the infections by H1N1 and H3N2 influenza viruses in mice. J Med Food (2012) 0.97
Immune responses and pathogenesis in immunocompromised chickens in response to infection with the H9N2 low pathogenic avian influenza virus. Virus Res (2008) 0.97
Cytoplasmic transduction peptide (CTP): new approach for the delivery of biomolecules into cytoplasm in vitro and in vivo. Exp Cell Res (2006) 0.96
Location of T-cell epitopes in nonstructural proteins 9 and 10 of type-II porcine reproductive and respiratory syndrome virus. Virus Res (2012) 0.96
An emerging recombinant cluster of nephropathogenic strains of avian infectious bronchitis virus in Korea. Infect Genet Evol (2011) 0.95
Serological responses after vaccination of growing pigs with foot-and-mouth disease trivalent (type O, A and Asia1) vaccine. Vet Microbiol (2013) 0.93
Fast duplex one-step reverse transcriptase PCR for rapid differential detection of West Nile and Japanese encephalitis viruses. J Clin Microbiol (2010) 0.93
Exchange of Newcastle disease viruses in Korea: the relatedness of isolates between wild birds, live bird markets, poultry farms and neighboring countries. Infect Genet Evol (2011) 0.93
Severe canine influenza in dogs correlates with hyperchemokinemia and high viral load. Virology (2011) 0.92